Abstract
Ayurveda, An Indian system of medicine has described several drugs from indigenous plant sources for use in the treatment of bronchial asthma and allergic disorders. Traditionally Fagonia schweinfurthii Hadidi (Family- Zygophylaceae) is used for allergies and other skin diseases. The current study evaluates the anti-histaminic activity of aqueous extract of F. schweinfurthii Hadidi and then anti-histaminic formulation (syrup) was prepared and evaluated for various parameters. Plant Fagonia schweinfurthii Hadidi was collected from local area. Aqueous extract was obtained by extraction of moderately coarse powder of F. schweinfurthii Hadidi was carried out by decoction method with water and dried. Anti-histaminic activity of plant extract was evaluated by using Guinea pig ileum and for the comparison of anti-histaminic activity ceterizine (10 mg) was used as model drug. In the present study it was found that aqueous extract of F. schweinfurthii Hadidi showed significant anti-histaminic activity. The outcomes of study showed that 16% and 18.8% inhibition in maximum response produced by histamine was observed for plant extract (1000 μg/ml) and standard drug (50 μg/ml) respectively when 5 μg/ml dose of histamine was used. From this study 2 g dose was selected for the preparation of syrup. The results indicate that aqueous extract of F. schweinfurthii Hadidi has significant anti-histaminic activity and syrup which contains 2 g of extract has similar anti-histaminic activity to marketed preparation.
Keywords: Aqueous extract, concentration response curve, fagonia.
The Natural Products Journal
Title:Screening of Anti-Histaminic Activity of Fagonia Schweinfurthii Hadidi in Guinea Pig Ileum and Formulate Anti-Histaminic Syrup
Volume: 5 Issue: 3
Author(s): Dinesh Puri, Anil Bhandari and Praveen Kumar Gaur
Affiliation:
Keywords: Aqueous extract, concentration response curve, fagonia.
Abstract: Ayurveda, An Indian system of medicine has described several drugs from indigenous plant sources for use in the treatment of bronchial asthma and allergic disorders. Traditionally Fagonia schweinfurthii Hadidi (Family- Zygophylaceae) is used for allergies and other skin diseases. The current study evaluates the anti-histaminic activity of aqueous extract of F. schweinfurthii Hadidi and then anti-histaminic formulation (syrup) was prepared and evaluated for various parameters. Plant Fagonia schweinfurthii Hadidi was collected from local area. Aqueous extract was obtained by extraction of moderately coarse powder of F. schweinfurthii Hadidi was carried out by decoction method with water and dried. Anti-histaminic activity of plant extract was evaluated by using Guinea pig ileum and for the comparison of anti-histaminic activity ceterizine (10 mg) was used as model drug. In the present study it was found that aqueous extract of F. schweinfurthii Hadidi showed significant anti-histaminic activity. The outcomes of study showed that 16% and 18.8% inhibition in maximum response produced by histamine was observed for plant extract (1000 μg/ml) and standard drug (50 μg/ml) respectively when 5 μg/ml dose of histamine was used. From this study 2 g dose was selected for the preparation of syrup. The results indicate that aqueous extract of F. schweinfurthii Hadidi has significant anti-histaminic activity and syrup which contains 2 g of extract has similar anti-histaminic activity to marketed preparation.
Export Options
About this article
Cite this article as:
Puri Dinesh, Bhandari Anil and Kumar Gaur Praveen, Screening of Anti-Histaminic Activity of Fagonia Schweinfurthii Hadidi in Guinea Pig Ileum and Formulate Anti-Histaminic Syrup, The Natural Products Journal 2015; 5 (3) . https://dx.doi.org/10.2174/2210315505666150707183856
DOI https://dx.doi.org/10.2174/2210315505666150707183856 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
Call for Papers in Thematic Issues
Ayurvedic medicinal therapeutic approaches for inflammatory and neurodegenerative disorders
Usually, in our elderly population, neurodegenerative disorders occur due to neuron death. Alzheimer?s disease (AD) is an irreversible and progressive neurodegenerative disease. Dementia is the leading cause of AD, which affects about 30 million people worldwide. According to the World Alzheimer report 2018, a new case of dementia develops every ...read more
Recent Advances in Biotransformation of Bioactive Terpenoids using Aspergillus niger
Biotransformation is the reaction catalyzed by biological catalysts of either isolated enzymes or whole cell cultures of microorganisms. This process has been extensively applied in the conversion of bioactive terpenoids with high regio- and stereospecifity. This process has been also applied in the lead discovery and development. Aspergillus niger has ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Recent Advances in Endocrine Metabolic Immune Disorders Drug Targeting: An Editorial Overview
Endocrine, Metabolic & Immune Disorders - Drug Targets Probiotics Role in Allergic Illness
Current Respiratory Medicine Reviews Epidemiology, Evolution, Transmission, and Therapeutics of COVID-19 Outbreak: An Update on the Status
Coronaviruses Chalcones as Versatile Synthons for the Synthesis of 5- and 6-membered Nitrogen Heterocycles
Current Organic Chemistry Contrast Agents in X-Ray Computed Tomography and Its Applications in Oncology
Anti-Cancer Agents in Medicinal Chemistry Evaluation of the Effects of 1,25 Vitamin D3 on Regulatory T Cells and T Helper 17 Cells in Vitamin D-deficient Women with Unexplained Recurrent Pregnancy Loss
Current Molecular Pharmacology Pipeline Pharmacogenetics: A Novel Approach to Integrating Pharmacogenetics into Drug Development
Current Pharmaceutical Design Erratum
Mini-Reviews in Medicinal Chemistry COVID-19 Treatment Success After Repeat Courses of Azithromycin: A Report of Three Cases
Infectious Disorders - Drug Targets Current and Experimental Antibody-Based Therapeutics: Insights, Breakthroughs, Setbacks and Future Directions
Current Molecular Medicine Biomarkers in Pediatric Lung Diseases Including Cystic Fibrosis
Current Respiratory Medicine Reviews Choline Alphoscerate (Alpha-Glyceryl-Phosphoryl-Choline) An Old Choline- containing Phospholipid with a Still Interesting Profile As Cognition Enhancing Agent
Current Alzheimer Research Pathway-Specific, Species, and Sub-Type Counterscreening for Better GPCR Hits in High Throughput Screening
Current Pharmaceutical Biotechnology Sulfation in Dog
Current Drug Metabolism Targeting Schistosome Histone Modifying Enzymes for Drug Development
Current Pharmaceutical Design Impact of Altered Early Infant Gut Microbiota Following Breastfeeding and Delivery Mode on Allergic Diseases
Inflammation & Allergy - Drug Targets (Discontinued) TLR7/9 Antagonists as Therapeutics for Immune-Mediated Inflammatory Disorders
Inflammation & Allergy - Drug Targets (Discontinued) Methods to Measure Target Site Penetration of Antibiotics in Critically Ill Patients
Current Clinical Pharmacology Analysis of TLC-Bioautography and TLC-Spot Visualization of <i>Atropa accuminata</i> and <i>Atropa belladonna</i> Extracts as Antioxidant and Antibacterial Agents Against Human Pathogenic Bacteria
Current Pharmaceutical Analysis Dendritic Cells in Pathogenesis of COPD
Current Pharmaceutical Design